Intermittent claudication: A risk profile from the Framingham Heart Study

Circulation

Volumn 96, Issue 1, 1997, Pages 44-49

  Murabito, Joanne M ^a,b   D'Agostino, Ralph B ^a,d   Silbershatz, Halit ^a,d   Wilson, Peter W F ^a,c  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d Boston University   (United States)

Author keywords

Claudication; Hypertension; Risk factors; Smoking

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; PRIORITY JOURNAL; RISK FACTOR; SEX; SURVIVAL;

EID: 0030811537     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.1.44     Document Type: Article

References (35)

1. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33:13-18.
2. Gillum RF. Peripheral arterial occlusive disease of the extremities in the United States: hospitalization and mortality. Am Heart J. 1990;120:1414-1418.
3. Schneider JR, McHorney CA, Malenka DJ, McDaniel MD, Walsh DB, Cronenwett JL. Functional health and well-being in patients with severe atherosclerotic peripheral vascular occlusive disease. Ann Vasc Surg. 1993;7:419-428.
4. Jonason T, Ringqvist I. Changes in peripheral blood pressures after five years of follow-up in non-operated patients with intermittent claudication. Acta Med Scand. 1986;220:127-132.
5. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand. 1982;211; 249-256.
6. Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication: effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand. 1987;221:253-260.
7. Joint National Committee. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med. 1993;153:154-183.
8. D'Agostino RB, Lee M, Belanger AJ, Cupples LA, Anderson KA, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501-1515.
9. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality: the Whitehall Study. Circulation. 1990;82:1925-1931.
10. Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell Prospective Heart Disease Study. Br Heart J. 1994;72:128-132.
11. Ingolfsson IO, Sigurdsson G, Sigvaldason H, Thorgeirsson G, Sigfusson N. A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol - the Reykjavik Study. J Clin Epidemiol. 1994;47:1237-1243.
12. Dagenais GR, Maurice S, Robitaille NM, Gingras S, Lupien PJ. Intermittent claudication in Quebec men from 1974-1986: the Quebec Cardiovascular Study. Clin Invest Med. 1991;14:93-100.
13. Simonsick EM, Guralnik JM, Hennekens CH, Wallace RB, Ostfeld AM. Intermittent claudication and subsequent cardiovascular disease in the elderly. J Gerontol A Biol Sci Med Sci. 1995;50A: M17-M22.
14. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27: 645-658.
15. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from non-invasive testing in a defined population. Circulation. 1985;71: 516-522.
16. Vogt MT, Cauley JA, Kuller LH, Hulley SB. Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol. 1993;137:559-568.
17. Kuller LH, Shemanski L, Patsy BM, Borhani NO, Gardin J, Haan MN, O'Leary DH, Savage PJ, Tell GS, Tracy R. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation. 1995;92:720-726.
18. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK, for the Cardiovascular Health Study (CHS) Collaborative Research Group. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993;88:837-845.
19. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA. 1993;270:487-489.
20. Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA. 1993;270:465-469.
21. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326: 381-386.
22. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-128.
23. O'Riordain DS, O'Donnell JA. Realistic expectations for the patient with intermittent claudication. Br J Surg. 1991;78: 861-863.
24. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Goldbourt U. Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol. 1994;140:418-430.
25. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk. 1994;1:333-339.
26. Fowkes FGR. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg. 1988,2:283-291.
27. Sayers RD, Thompson MM, Dunlop P, London NJ, Bell PR. The fate of infrainguinal PTFE grafts and an analysis of factors affecting outcome. Eur J Vasc Surg. 1994;8:607-610.
28. Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med. 1990:113:135-146.
29. Ameli FM, Stein M, Provan JL, Prosser R. The effect of postoperative smoking on femoropopliteal bypass grafts. Ann Vasc Surg. 1989;3:20-25.
30. Lepantalo M., Lassila R. Smoking and occlusive peripheral arterial disease: clinical review. Eur J Surg. 1991;157:83-87.
31. Mulcahy R. Influence of cigarette smoking on morbidity and mortality after myocardial infarction. Br Heart J. 1983;49:410-415.
32. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ, for Participants in the Coronary Artery Surgery Study. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. N Engl J Med. 1988;319:1365-1369.
33. Voors AA, van Brussel BL, Plokker HWT, Ernst SMPG, Ernst NM, Koomen EM, Tijssen JGP, Vermeulen FEE. Smoking and cardiac events after venous coronary bypass surgery: a 15-year follow-up study. Circulation. 1996;93:42-47.
34. Vogt MT, Wolfson SK, Kuller LH. Segmental arterial disease in the lower extremities: correlates of disease and relationship to mortality. J Clin Epidemiol. 1993;46:1267-1276.
35. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug therapy in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.